
Publikationen von Yu Yan
Alle Typen
Zeitschriftenartikel (7)
1.
Zeitschriftenartikel
282, 104925 (2023)
Chronic fluoxetine treatment in socially-isolated rats modulates the prefrontal cortex synaptoproteome. JOURNAL OF PROTEOMICS 2.
Zeitschriftenartikel
44 (1), S. 30 - 42 (2023)
Delineation of biomarkers and molecular pathways of residual effects of fluoxetine treatment in juvenile rhesus monkeys by proteomic profiling. ZOOLOGICAL RESEARCH 3.
Zeitschriftenartikel
501, S. 52 - 71 (2022)
Chronic Fluoxetine Treatment of Socially Isolated Rats Modulates Prefrontal Cortex Proteome. NEUROSCIENCE 4.
Zeitschriftenartikel
110 (14), S. 2283 - 2298.e9 (2022)
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2. NEURON 5.
Zeitschriftenartikel
29 (3), e6, S. 373 - 385 (2022)
Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth. CELL CHEMICAL BIOLOGY 6.
Zeitschriftenartikel
4 (1), S. 304 - 317 (2022)
An Artemisinin Derivative ART1 Induces Ferroptosis by Targeting the HSD17B4 Protein Essential for Lipid Metabolism and Directly Inducing Lipid Peroxidation. CCS CHEMISTRY 7.
Zeitschriftenartikel
129, S. 8 - 14 (2020)
Paroxetine binding and activation of phosphofructokinase implicates energy metabolism in antidepressant mode of action. JOURNAL OF PSYCHIATRIC RESEARCH Hochschulschrift - Doktorarbeit (1)
8.
Hochschulschrift - Doktorarbeit
Towards elucidating the molecular modes of action of two types of antidepressant drugs using proteomics. Dissertation, 140 S., Ludwig-Maximilians-Universität München, München (2021)